Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
18.58
+1.57 (9.26%)
At close: Jun 6, 2025, 4:00 PM
18.51
-0.06 (-0.35%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Beam Therapeutics Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Beam Therapeutics stock ranges from a low of $25 to a high of $80. The average analyst price target of $48.9 forecasts a 163.26% increase in the stock price over the next year.
Price Target: $48.90 (+163.26%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 7, 2025.
Analyst Ratings
The average analyst rating for Beam Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 3 | 5 | 5 | 5 | 5 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 4 | 4 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Maintains $78 → $55 | Strong Buy | Maintains | $78 → $55 | +196.10% | May 7, 2025 |
Wells Fargo | Wells Fargo | Buy Maintains $75 → $70 | Buy | Maintains | $75 → $70 | +276.85% | May 7, 2025 |
Barclays | Barclays | Hold Maintains $31 → $25 | Hold | Maintains | $31 → $25 | +34.59% | May 7, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +330.69% | Apr 7, 2025 |
B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $42 | Hold → Strong Buy | Upgrades | $42 | +126.11% | Mar 28, 2025 |
Financial Forecast
Revenue This Year
54.07M
from 63.52M
Decreased by -14.87%
Revenue Next Year
59.50M
from 54.07M
Increased by 10.03%
EPS This Year
-4.72
from -4.58
EPS Next Year
-4.72
from -4.72
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 115.5M | 168.0M | 126.0M | ||
Avg | 54.1M | 59.5M | 69.7M | ||
Low | 6.9M | n/a | 29.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 81.8% | 210.7% | 111.8% | ||
Avg | -14.9% | 10.0% | 17.1% | ||
Low | -89.2% | - | -50.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.43 | -2.87 | -2.89 | ||
Avg | -4.72 | -4.72 | -4.88 | ||
Low | -5.64 | -5.68 | -6.25 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.